Depression and neuroticism in patients with chronic hepatitis C: Correlation with peripheral blood mononuclear cells activation

Journal of Clinical Virology

Volumn 60, Issue 2, 2014, Pages 105-111

  Pawlowski, Tomasz ^a   Radkowski, Marek ^b   Małyszczak, Krzysztof ^a   Inglot, Małgorzata ^a   Zalewska, Małgorzata ^a   Jablonska, Joanna ^b   Laskus, Tomasz ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Cognitive; Immune activation; Neuroticism

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; COLONY STIMULATING FACTOR 1; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 16; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MYXOVIRUS RESISTANCE PROTEIN A; PEGINTERFERON ALPHA2A; RANTES; RIBAVIRIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; MESSENGER RNA;

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; CELL ACTIVATION; CLINICAL ARTICLE; DEPRESSION; EYSENCK PERSONALITY QUESTIONNAIRE; FEMALE; HEPATITIS C; HUMAN; IMMUNE RESPONSE; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NEUROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; VIRUS LOAD; ANXIETY DISORDERS; BIOSYNTHESIS; COMPLICATION; GENE EXPRESSION PROFILING; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MIDDLE AGED; MONONUCLEAR CELL; PATHOLOGY;

ADULT; AGED; ANXIETY DISORDERS; CYTOKINES; DEPRESSION; FEMALE; GENE EXPRESSION PROFILING; HEPATITIS C, CHRONIC; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84900299462     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2014.03.004     Document Type: Article

References (49)

1. Barkhuizen A., Rosen H.R., Wolf S., Flora K., Benner K., Bennett R.M. Musculoskeletal pain and fatigue are associated with chronic hepatitis C: a report of 239 hepatology clinic patients. Am J Gastroenterol 1999, 94:1355-1360.
2. Forton D.M., Thomas H.C., Murphy C.A., Allsop J.M., Foster G.R., Main J., et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology (Baltimore, MD) 2002, 35:433-439.
3. Hilsabeck R.C., Perry W., Hassanein T.I. Neuropsychological impairment in patients with chronic hepatitis C. Hepatology (Baltimore, MD) 2002, 35:440-446.
4. Forton D.M., Allsop J.M., Main J., Foster G.R., Thomas H.C., Taylor-Robinson S.D. Evidence for a cerebral effect of the hepatitis C virus. Lancet 2001, 358:38-39.
5. Taylor-Robinson S.D. Applications of magnetic resonance spectroscopy to chronic liver disease. Clin Med 2001, 1:54-60.
6. Marcus C.D., Taylor-Robinson S.D., Sargentoni J., Ainsworth J.G., Frize G., Easterbrook P.J., et al. 1H MR spectroscopy of the brain in HIV-1-seropositive subjects: evidence for diffuse metabolic abnormalities. Metab Brain Dis 1998, 13:123-136.
7. Meyerhoff D.J., Bloomer C., Cardenas V., Norman D., Weiner M.W., Fein G. Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients. Neurology 1999, 52:995-1003.
8. Weissenborn K., Krause J., Bokemeyer M., Hecker H., Schuler A., Ennen J.C., et al. Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol 2004, 41:845-851.
9. McAndrews M.P., Farcnik K., Carlen P., Damyanovich A., Mrkonjic M., Jones S., et al. Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. Hepatology (Baltimore, MD) 2005, 41:801-808.
10. Radkowski M., Wilkinson J., Nowicki M., Adair D., Vargas H., Ingui C., et al. Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol 2002, 76:600-608.
11. Wilkinson J., Radkowski M., Laskus T. Hepatitis C virus neuroinvasion: identification of infected cells. J Virol 2009, 83:1312-1319.
12. Letendre S., Paulino A.D., Rockenstein E., Adame A., Crews L., Cherner M., et al. Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. J Infect Dis 2007, 196:361-370.
13. Forton D.M., Karayiannis P., Mahmud N., Taylor-Robinson S.D., Thomas H.C. Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J Virol 2004, 78:5170-5183.
14. Hickey W.F. Leukocyte traffic in the central nervous system: the participants and their roles. Semin Immunol 1999, 11:125-137.
15. Hickey W.F., Vass K., Lassmann H. Bone marrow-derived elements in the central nervous system: an immunohistochemical and ultrastructural survey of rat chimeras. J Neuropathol Exp Neurol 1992, 51:246-256.
16. Unger E.R., Sung J.H., Manivel J.C., Chenggis M.L., Blazar B.R., Krivit W. Male donor-derived cells in the brains of female sex-mismatched bone marrow transplant recipients: a Y-chromosome specific in situ hybridization study. J Neuropathol Exp Neurol 1993, 52:460-470.
17. Knodell R.G., Ishak K.G., Black W.C., Chen T.S., Craig R., Kaplowitz N., et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology (Baltimore, MD) 1981, 1:431-435.
18. Wilkinson J., Radkowski M., Eschbacher J.M., Laskus T. Activation of brain macrophages/microglia cells in hepatitis C infection. Gut 2010, 59:1394-1400.
19. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, CA) 2001, 25:402-408.
20. Bas A., Forsberg G., Hammarstrom S., Hammarstrom M.L. Utility of the housekeeping genes 18S rRNA, beta-actin and glyceraldehyde-3-phosphate-dehydrogenase for normalization in real-time quantitative reverse transcriptase-polymerase chain reaction analysis of gene expression in human T lymphocytes. Scand J Immunol 2004, 59:566-573.
21. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961, 4:561-571.
22. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979, 134:382-389.
23. Eysenck H.J., Eysenck S.B.J. Manual of the Eysenck Personality Inventory 1975, Hodder & Stoughton, London.
24. Kendler K.S., Kuhn J., Prescott C.A. The interrelationship of neuroticism, sex, and stressful life events in the prediction of episodes of major depression. Am J Psychiatry 2004, 161:631-636.
25. Brabers N.A., Nottet H.S. Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia. Eur J Clin Invest 2006, 36:447-458.
26. Gelbard H.A., Dzenko K.A., DiLoreto D., del Cerro C., del Cerro M., Epstein L.G. Neurotoxic effects of tumor necrosis factor alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: implications for AIDS neuropathogenesis. Dev Neurosci 1993, 15:417-422.
27. Bezzi P., Domercq M., Brambilla L., Galli R., Schols D., De Clercq E., et al. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci 2001, 4:702-710.
28. Fine S.M., Angel R.A., Perry S.W., Epstein L.G., Rothstein J.D., Dewhurst S., et al. Tumor necrosis factor alpha inhibits glutamate uptake by primary human astrocytes. Implications for pathogenesis of HIV-1 dementia. J Biol Chem 1996, 271:15303-15306.
29. Saha R.N., Pahan K. Tumor necrosis factor-alpha at the crossroads of neuronal life and death during HIV-associated dementia. J Neurochem 2003, 86:1057-1071.
30. Radkowski M., Bednarska A., Horban A., Stanczak J., Wilkinson J., Adair D.M., et al. Infection of primary human macrophages with hepatitis C virus in vitro: induction of tumour necrosis factor-alpha and interleukin 8. J Gen Virol 2004, 85:47-59.
31. Machida K., Cheng K.T., Sung V.M., Levine A.M., Foung S., Lai M.M. Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6. J Virol 2006, 80:866-874.
32. Polyak S.J., Khabar K.S., Paschal D.M., Ezelle H.J., Duverlie G., Barber G.N., et al. Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response. J Virol 2001, 75:6095-6106.
33. Muller N., Schwarz M.J. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatry 2007, 12:988-1000.
34. Pavon L., Sandoval-Lopez G., Eugenia Hernandez M., Loria F., Estrada I., Perez M., et al. Th2 cytokine response in major depressive disorder patients before treatment. J Neuroimmunol 2006, 172:156-165.
35. Fitzgerald P., O'Brien S.M., Scully P., Rijkers K., Scott L.V., Dinan T.G. Cutaneous glucocorticoid receptor sensitivity and pro-inflammatory cytokine levels in antidepressant-resistant depression. Psychol Med 2006, 36:37-43.
36. Schlatter J., Ortuno F., Cervera-Enguix S. Differences in interleukins' patterns between dysthymia and major depression. Eur Psychiatry 2001, 16:317-319.
37. Sluzewska A., Rybakowski J., Bosmans E., Sobieska M., Berghmans R., Maes M., et al. Indicators of immune activation in major depression. Psychiatry Res 1996, 64:161-167.
38. Tsao C.W., Lin Y.S., Chen C.C., Bai C.H., Wu S.R. Cytokines and serotonin transporter in patients with major depression. Prog Neuro-psychopharmacol Biol Psychiatry 2006, 30:899-905.
39. Weiss G., Murr C., Zoller H., Haun M., Widner B., Ludescher C., et al. Modulation of neopterin formation and tryptophan degradation by Th1- and Th2-derived cytokines in human monocytic cells. Clin Exp Immunol 1999, 116:435-440.
40. Grohmann U., Fallarino F., Puccetti P. Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol 2003, 24:242-248.
41. Raison C.L., Borisov A.S., Majer M., Drake D.F., Pagnoni G., Woolwine B.J., et al. Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biol Psychiatry 2009, 65:296-303.
42. Pockros P.J., Hamzeh F.M., Martin P., Lentz E., Zhou X., Govindarajan S., et al. Histologic outcomes in hepatitis C-infected patients with varying degrees of virologic response to interferon-based treatments. Hepatology (Baltimore, MD) 2010, 52:1193-2000.
43. Vigano S., Perreau M., Pantaleo G., Harari A. Positive and negative regulation of cellular immune responses in physiologic conditions and diseases. Clin Dev Immunol 2012, 2012. 485781.
44. Haller O., Frese M., Kochs G. Mx proteins: mediators of innate resistance to RNA viruses. Revue scientifique et technique (International Office of Epizootics) 1998, 17:220-230.
45. Machida K., Cheng K.T., Sung V.M., Lee K.J., Levine A.M., Lai M.M. Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes. J Virol 2004, 78:8835-8843.
46. Su A.I., Pezacki J.P., Wodicka L., Brideau A.D., Supekova L., Thimme R., et al. Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci U S A 2002, 99:15669-15674.
47. Guidotti L.G., Chisari F.V. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001, 19:65-91.
48. Guidotti L.G., Chisari F.V. Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol 2006, 1:23-61.
49. Fallahi P., Ferri C., Ferrari S.M., Corrado A., Sansonno D., Antonelli A. Cytokines and HCV-related disorders. Clin Dev Immunol 2012, 2010:468107.